Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11485732 Compounds and uses thereof

Patent 11485732 was granted and assigned to Foghorn Therapeutics on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foghorn Therapeutics

Current Assignee

Foghorn Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11485732

Date of Patent

November 1, 2022

Patent Application Number

17162103

Date Filed

January 29, 2021

Patent Citations

‌

US Patent 10131637 Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

‌

US Patent 10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

‌

US Patent 10976320 Methods for identifying and treating cancer patients

Patent Primary Examiner

CPC Code

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11485732 Compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API